课题基金 / 基金详情

项目摘要

项目成果

Alan L Rothman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The long-term objective of this project is to define the immunological mechanisms that determine the outcome of dengue virus (DV) infection. A large body of information supports the model of immunopathogenesis of severe dengue disease; however, open questions remain about the principal determinants of disease. DV interaction with host innate and adaptive immunity responses is highly complex, and can result in the production of pro-inflammatory, antiinflammatory, and/or vasoactive cytokines. This Project seeks to understand the contribution of individual components of the immune response to different clinical disease manifestations. These findings will be important for vaccine development, by identifying the key immunologic correlates of vaccine-induced protection as opposed to immunopathology on subsequent exposure to DV. The Specific Aims of this Project are: 1. to define the viral and innate host determinants of the cellular response to DV infection, by determining the dendritic cell (DC) cytokine response to DV strains associated with different disease severity and the association of DC responses with host genotypes; 2. to define the immunological mechanisms contributing to clinical disease in acute DV infection, by determining the kinetics of activation and expansion of DV-specific B cells and T cells; 3. to define immunological correlates of the response to tetravalent DV immunization, by determining the associations between pre-existing DV-specific immunity and the response to vaccination and between the vaccine-induced DV-specific immunity and clinical outcome (adverse events, protection, and breakthrough DV infections). Dengue is an important tropical mosquito-borne viral disease that causes shock as a result of the body's immune response. We will study how different parts of the host immune system react to infection with dengue virus to understand how virus infection causes disease. This research will help guide the development of vaccines and new treatments for dengue.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Elimination of flavivirus infected target cells by ADCC
  • 批准号:
    10170256
  • 项目类别:
  • 资助金额:
    $19.66万
  • 财政年份:
    2020
  • 负责人:
    Alan L Rothman
  • 依托单位:
Elimination of flavivirus infected target cells by ADCC
  • 批准号:
    10057300
  • 项目类别:
  • 资助金额:
    $23.36万
  • 财政年份:
    2020
  • 负责人:
    Alan L Rothman
  • 依托单位:
Immune-Based Interventions Against Infectious Diseases
  • 批准号:
    8432209
  • 项目类别:
  • 资助金额:
    $239.09万
  • 财政年份:
    2013
  • 负责人:
    Alan L Rothman
  • 依托单位:
Immune-Based Interventions Against Infectious Diseases
  • 批准号:
    9275512
  • 项目类别:
  • 资助金额:
    $185.57万
  • 财政年份:
    2013
  • 负责人:
    Alan L Rothman
  • 依托单位:
海外基金